The consistent increase in the serum concentration of PRL in metoclopramide-treated mice was considered to constitute hyperprolactinaemia and correlated with the premature onset of disease symptoms in lupus-prone mice (see below). The gene discussed is PRL; the disease is hyperpituitarism.